Therapeutic Area | MeSH |
---|---|
signs and symptoms pathological conditions | D013568 |
Brand Name | Status | Last Update |
---|---|---|
oxandrin | 2007-04-09 | |
oxandrolone | ANDA | 2022-04-29 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
growth disorders | — | D006130 | — |
emaciation | — | D004614 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Disease | D004194 | EFO_0000408 | R69 | 1 | — | — | — | — | 1 |
Drug common name | Oxandrolone |
INN | oxandrolone |
Description | Oxandrolone is a 3-oxo steroid, an oxa-steroid, a 17beta-hydroxy steroid and an anabolic androgenic steroid. It has a role as an androgen and an anabolic agent. |
Classification | Small molecule |
Drug class | androgens; steroids (not prednisolone derivatives) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O |
PDB | — |
CAS-ID | 53-39-4 |
RxCUI | — |
ChEMBL ID | CHEMBL1200436 |
ChEBI ID | 7820 |
PubChem CID | 5878 |
DrugBank | DB00621 |
UNII ID | 7H6TM3CT4L (ChemIDplus, GSRS) |